Navy@3x
Navy@3x

Creating value through relationships

Oxular is actively partnering with industry peers to utilize the potential of our technology across multiple modalities and indications.

Creating value through relationships

Oxular is actively partnering with industry peers to utilize the potential of our technology across multiple modalities and indications.

Opportunities for partnering

Targeted, routine suprachoroidal delivery​

Our drug administration technology enables routine administration to deliver drugs to specific back-of-eye tissues, including the suprachoroidal spaces.

Long-lasting,
efficacious treatments

Our drug formulations are designed to suit the unique ocular environments into which they are delivered, resulting in better kinetics and therapeutic benefits. They can provide treatment effects lasting up to 12 months from a single administration.

Indications

  • Geographic atrophy /
    intermediate AMD
  • Neovascular AMD
  • Uveal melanoma
  • Neuroprotection
  • Front-of-eye

Modalities

  • Small molecules
  • AAV gene therapies
  • Peptides/proteins
  • Antibodies
  • siRNA

If you would like to discuss a potential partnership with Oxular, please contact us via the form linked below.

Contact Us
Scroll to Top